We are live on
!
Find out more
OCM
Osterweis Capital Management Portfolio holdings
AUM
$1.94B
1-Year Est. Return
20.77%
This Fund
S&P 500
This Quarter
Est. Return
-7.62%
1 Year Est. Return
+20.77%
3 Year Est. Return
+69.82%
5 Year Est. Return
+88.03%
10 Year Est. Return
+482.02%
AUM
$1.23B
AUM Growth
-$215M
(-15%)
Cap. Flow
-$237M
Cap. Flow
% of AUM
-19.24%
Top 10 Holdings %
Top 10 Hldgs %
31.16%
Holding
132
New
15
Increased
26
Reduced
40
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
L3Harris
LHX
|
+$25.7M |
| 2 |
Sysco
SYY
|
+$23.1M |
| 3 |
Ross Stores
ROST
|
+$20.2M |
| 4 |
Union Pacific
UNP
|
+$14.5M |
| 5 |
Air Products & Chemicals
APD
|
+$12.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brookfield
BN
|
+$48.5M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$33.8M |
| 3 |
AL
Air Lease Corp
AL
|
+$25.2M |
| 4 |
Boeing
BA
|
+$23.7M |
| 5 |
Enterprise Products Partners
EPD
|
+$19.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.53% |
| 2 | Healthcare | 15.77% |
| 3 | Financials | 7.79% |
| 4 | Communication Services | 7.68% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OPRA
101
Opera Ltd
OPRA
$1.79B
| – | – |
-103,520
| Closed | -$958K |
|
|
SCHW
102
Charles Schwab
SCHW
$188B
| – | – |
-709,878
| Closed | -$33.8M |
|
103
Silicon Laboratories
SLAB
$7.2B
| – | – |
-36,110
| Closed | -$4.19M |
|
104
Thermo Fisher Scientific
TMO
$222B
| – | – |
-625
| Closed | -$203K |
|
105
Tandem Diabetes Care
TNDM
$1.59B
| – | – |
-65,665
| Closed | -$3.91M |
|
106
LendingTree
TREE
$453M
| – | – |
-5,380
| Closed | -$1.63M |
|
107
US Foods
USFD
$23.9B
| – | – |
-301,986
| Closed | -$12.7M |
|
108
Vericel Corp
VCEL
$2.25B
| – | – |
-172,220
| Closed | -$3M |
|
109
W.R. Berkley
WRB
$26.3B
| – | – |
-8,692
| Closed | -$267K |
|
110
Yeti Holdings
YETI
$3.99B
| – | – |
-67,340
| Closed | -$2.34M |
|
|
MMP
111
DELISTED
Magellan Midstream Partners, L.P.
MMP
| – | – |
-269,868
| Closed | -$17M |
|
|
ABMD
112
DELISTED
Abiomed Inc
ABMD
| – | – |
-9,755
| Closed | -$1.66M |
|
|
PLAN
113
DELISTED
Anaplan, Inc.
PLAN
| – | – |
-74,345
| Closed | -$3.9M |
|
Similar funds
AAA
FFH
BC
HCL
HC
CC
FC
DCM
Osterweis Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Osterweis Capital Management held 132 positions worth $1.23B, down 15% from $1.45B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Osterweis Capital Management withdrew a net $237M in Q1 2020, closing 24 positions and reducing 40 holdings. Its most notable exit was Brookfield, an estimated $48.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Osterweis Capital Management opened a new position in L3Harris worth $22.6M.
- Osterweis Capital Management's largest Q1 2020 buy was L3Harris: 125,450 shares worth $22.6M.
- Osterweis Capital Management added most to Union Pacific in Q1 2020, an estimated $14.5M increase.
- Osterweis Capital Management's biggest Q1 2020 reduction was Enterprise Products Partners, cutting an estimated $19.1M.
- Osterweis Capital Management fully exited Brookfield in Q1 2020, selling an estimated $48.5M.
- Osterweis Capital Management's ten largest holdings make up 31% of its $1.23B portfolio in Q1 2020.
- Osterweis Capital Management opened 15 new positions and closed 24 in Q1 2020.
- Osterweis Capital Management's portfolio value fell 15% quarter-over-quarter to $1.23B.
Based on Osterweis Capital Management's 13F filing for Q1 2020, filed 15 May 2020.